Literature DB >> 12621050

Decreased CCA-addition in human mitochondrial tRNAs bearing a pathogenic A4317G or A10044G mutation.

Yukihide Tomari1, Narumi Hino, Takashi Nagaike, Tsutomu Suzuki, Takuya Ueda.   

Abstract

Pathogenic point mutations in mitochondrial tRNA genes are known to cause a variety of human mitochondrial diseases. Reports have associated an A4317G mutation in the mitochondrial tRNA(Ile) gene with fatal infantile cardiomyopathy and an A10044G mutation in the mitochondrial tRNA(Gly) gene with sudden infant death syndrome. Here we demonstrate that both mutations inhibit in vitro CCA-addition to the respective tRNA by the human mitochondrial CCA-adding enzyme. Structures of these two mutant tRNAs were examined by nuclease probing. In the case of the A4317G tRNA(Ile) mutant, structural rearrangement of the T-arm region, conferring an aberrantly stable T-arm structure and an increased T(m) value, was clearly observed. In the case of the A10044G tRNA(Gly) mutant, high nuclease sensitivity in both the T- and D-loops suggested a weakened interaction between the loops. These are the first reported instances of inefficient CCA-addition being one of the apparent molecular pathogeneses caused by pathogenic point mutations in human mitochondrial tRNA genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621050     DOI: 10.1074/jbc.M213216200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

2.  Association of mitochondrial genomic background with risk of Multiple System Atrophy.

Authors:  Rebecca R Valentino; Michael G Heckman; Patrick W Johnson; Alexandra I Soto-Beasley; Ronald L Walton; Shunsuke Koga; Ryan J Uitti; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2020-10-29       Impact factor: 4.891

3.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

4.  Pathology-related mutation A7526G (A9G) helps in the understanding of the 3D structural core of human mitochondrial tRNA(Asp).

Authors:  Marie Messmer; Agnès Gaudry; Marie Sissler; Catherine Florentz
Journal:  RNA       Date:  2009-06-17       Impact factor: 4.942

5.  Contribution of the tRNAIle 4317A→G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A→G mutation.

Authors:  Feilong Meng; Zheyun He; Xiaowen Tang; Jing Zheng; Xiaofen Jin; Yi Zhu; Xiaoyan Ren; Mi Zhou; Meng Wang; Shasha Gong; Jun Qin Mo; Qiang Shu; Min-Xin Guan
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

6.  Decreased aminoacylation in pathology-related mutants of mitochondrial tRNATyr is associated with structural perturbations in tRNA architecture.

Authors:  Luc Bonnefond; Catherine Florentz; Richard Giegé; Joëlle Rudinger-Thirion
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

Review 7.  CCA addition to tRNA: implications for tRNA quality control.

Authors:  Ya-Ming Hou
Journal:  IUBMB Life       Date:  2010-04       Impact factor: 3.885

8.  Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations.

Authors:  Raquel Moreno-Loshuertos; Gustavo Ferrín; Rebeca Acín-Pérez; M Esther Gallardo; Carlo Viscomi; Acisclo Pérez-Martos; Massimo Zeviani; Patricio Fernández-Silva; José Antonio Enríquez
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

Review 9.  Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease.

Authors:  Christopher A Powell; Thomas J Nicholls; Michal Minczuk
Journal:  Front Genet       Date:  2015-03-10       Impact factor: 4.599

10.  ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy.

Authors:  Tobias B Haack; Robert Kopajtich; Peter Freisinger; Thomas Wieland; Joanna Rorbach; Thomas J Nicholls; Enrico Baruffini; Anett Walther; Katharina Danhauser; Franz A Zimmermann; Ralf A Husain; Jessica Schum; Helen Mundy; Ileana Ferrero; Tim M Strom; Thomas Meitinger; Robert W Taylor; Michal Minczuk; Johannes A Mayr; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2013-07-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.